One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-141087
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 2 |
Affiliation: McGill University, University of Calgary, University of Alberta, Ottawa Hospital, Juravinski Cancer Centre, BC Cancer Agency, CancerCare Manitoba, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Thunder Bay Regional Research Institute, Thunder Bay Regional Health Sciences Centre, Saint John Regional Hospital, Micropharma (Canada), University Health Network, Princess Margaret Cancer CentreA Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
